The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Regulation of Phosphorylation of Thr-308 of Akt, Cell Proliferation, and Survival by the B55α Regulatory Subunit Targeting of the Protein Phosphatase 2A Holoenzyme to Akt
Open accessAbstract
Akt is a protein serine/threonine kinase that is involved in the regulation of diverse cellular processes. Phosphorylation of Akt at regulatory residues Thr-308 and Ser-473 leads to its full activation. The protein phosphatase 2A (PP2A) has long been known to negatively regulate Akt activity. The PP2A holoenzyme consists of the structural subunit (A), catalytic subunit (C), and a variable regulatory subunit (B). Here we report the identification of the specific B regulatory subunit that targets the PP2A holoenzyme to Akt. We found endogenous association of PP2A AB55C holoenzymes with Akt by co-immunoprecipitation analyses in pro-lymphoid FL5.12 cells. Akt was shown to associate with ectopically expressed B55alpha subunit in NIH3T3 cells. The direct interaction between B55alpha subunit and Akt was confirmed using in vitro pulldown analyses. Intriguingly, we found that overexpression of B55alpha subunit significantly impaired phosphorylation at Thr-308, but to a lesser extent at Ser-473 of Akt in both FL5.12 and NIH3T3 cells. Concomitantly, phosphorylation of a subset of Akt substrates, including FoxO3a, was substantially decreased by B55alpha overexpression in these cells. Silencing of B55alpha expression markedly increased phosphorylation at Thr-308 but not at Ser-473 in both FL5.12 cells and NIH3T3 cells. Consistently, PP2A AB55alphaC holoenzymes preferentially dephosphorylated phospho-Thr-308 rather than phospho-Ser-473 in in vitro dephosphorylation assays. Furthermore, B55alpha overexpression retarded proliferation of NIH3T3 cells, and knockdown of B55alpha expression increased survival of FL5.12 cells upon interleukin-3 deprivation. Together, our data demonstrate that B55alpha-dependent targeting of the PP2A holoenzyme to Akt selectively regulates Akt phosphorylation at Thr-308 to regulate cell proliferation and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistently, an in vitro dephosphorylation assay showed that PP2A/B55α dephosphorylates AKT on Thr308 preferentially over Ser473, suggesting that B55α selectively and directly regulates AKT phosphorylation on Thr308 (Kuo et al., 2008).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Kuo et al., 2008
In the citing paper
“In the PI3K/AKT pathway, both PI3K and AKT downstream signaling factors are substrates of PP2A (Kuo et al., 2008; Petritsch et al., 2000).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Kuo et al., 2008
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,214
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,665
Flagged first, then by citations
Research works printed but not linked: 3
- Bellacosa, 1991, Science, 254, 274
- Healy, 1991, Mol. Cell. Biol., 11, 5767
- Liu, 2004, Am. J. Physiol., 286, H2204
Cited by
Sorted by citations
Items 201–300 of 372
Janghorban, M., Langer, E. M., Wang, X., Zachman, D., Daniel, C. J., Hooper, J., Fleming, W. H., Agarwal, A., & Sears, R. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188910 · Cited by 19
Seo, S., Shin, J., Ham, D.-W., & Shin, E. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113366 · Cited by 19
Zhang, Y., Wang, X. T., Li, A., Guan, Y., Shen, P., Ni, Y., & Han, X. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.07.001 · Cited by 19
Stable SET knockdown in breast cell carcinoma inhibits cell migration and invasion
Li, J., Yang, X., Ren, X., Meng, X.-J., Huang, H., Zhao, Q.-H., Yuan, J., Hong, W., Xia, B., Huang, X., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.013 · Cited by 19
Chen, G., Li, T., Xiao, J., Wang, J., Shang, Q., Qian, H., Qiao, C., Zhang, P., Chen, T., & Liu, X. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02966-8 · Cited by 19
Cancer‐derived IgG involved in cisplatin resistance through PTP‐BAS/Src/PDK1/AKT signaling pathway
Wang, L., & Gan, Y. (2020) · Oral Diseases · doi:10.1111/odi.13583 · Cited by 19
Autophagy signals orchestrate chemoresistance of gynecological cancers
Tam, C., Rao, S., Waye, M. M. Y., Ng, T. B., & Wang, C. C. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188525 · Cited by 19
Myosin 1b Regulates Nuclear AKT Activation by Preventing Localization of PTEN in the Nucleus
Yu, Y., Xiong, Y., Ladeiras, D., Yang, Z., & Ming, X. (2019) · iScience · doi:10.1016/j.isci.2019.07.010 · Cited by 18
Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities
Sergienko, N. M., Donner, D. G., Delbridge, L. M. D., McMullen, J. R., & Weeks, K. L. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110213 · Cited by 19
Regulation of Metabolism by Mitochondrial MUL1 E3 Ubiquitin Ligase
Cilenti, L., Mahar, R., Gregorio, J. D., Ambivero, C. T., Merritt, M. E., & Zervos, A. S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.904728 · Cited by 18
The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers
Wang, F., Zhou, C., Zhu, Y., & Keshavarzi, M. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09884-3 · Cited by 21
MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells
Jabłońska, E., Górniak, P., Szydłowski, M., Sewastianik, T., Białopiotrowicz, E., Polak, A., Warzocha, K., & Juszczyński, P. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.09.011 · Cited by 18
Morande, P. E., Sivina, M., Uriepero, A., Seija, N., Berca, C., Fresia, P., Landoni, A. I., Noia, J. M. D., Burger, J. A., & Oppezzo, P. (2019) · Blood · doi:10.1182/blood-2018-09-876292 · Cited by 19
Gagne, C., Piot, A., & Brake, W. G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.797577 · Cited by 18
Ishikura, S., Iwaihara, Y., Tanaka, Y., Luo, H. L., Nishi, K., Doi, K., Koyanagi, M., Okamura, T., Tsunoda, T., & Shirasawa, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.723734 · Cited by 18
Li, J., An, R., Lai, S., Li, L., Liu, S., & Xu, H. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.07.009 · Cited by 19
Rasool, R. U., O’Connor, C. M., Das, C. K., Alhusayan, M., Verma, B. K., Islam, S., Frohner, I. E., Deng, Q., Mitchell-Velasquez, E., Sangodkar, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40760-6 · Cited by 17
Yang, R., Yang, L., Qiu, F., Zhang, L., Wang, H., Yang, X., Deng, J., Fang, W., Zhou, Y., & Lü, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077285 · Cited by 17
Zhang, W., Zheng, X., Meng, T., You, H., Dong, Y., Xing, J., & Chen, S. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1245307 · Cited by 17
Li, L., Liu, H., Hu, X., Huang, Y., Wang, Y., He, Y., & Lei, Q. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8852 · Cited by 18
Kubiniok, P., Finicle, B. T., Piffaretti, F., McCracken, A. N., Perryman, M. S., Hanessian, S., Edinger, A. L., & Thibault, P. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001053 · Cited by 17
Liu, S., Zhou, L., Wang, H. F., Li, G., Xie, Q., & Hu, B. (2019) · Neoplasma · doi:10.4149/neo_2019_190206n108 · Cited by 17
Zhang, R., Zhu, H., Yuan, Y., Wang, Y., & Tian, Z. (2020) · Oncology Reports · doi:10.3892/or.2020.7776 · Cited by 16
Protein Phosphatase 2A: Role in T Cells and Diseases
Roy, S., & Batra, L. (2023) · Journal of Immunology Research · doi:10.1155/2023/4522053 · Cited by 19
Tsukamoto, T., Hama, S., Kogure, K., & Tsuchiya, H. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.031 · Cited by 16
Redox control of cytosolic Akt phosphorylation in PTEN null cells
Luo, L., Kumar, J. K., & Clement, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.566 · Cited by 16
Chen, L., & Wang, H. (2019) · Toxicology · doi:10.1016/j.tox.2019.02.017 · Cited by 16
Mo, S.-T., Chiang, S.-J., Lai, T.-Y., Cheng, Y.-L., Chung, C.-E., Kuo, S. C. H., Reece, K. M., Chen, Y.-C., Chang, N., Wadzinski, B. E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116074 · Cited by 17
Self-citationLiu, X., Wang, M., Sun, G.-Q., Wang, B., Jiang, K., Shao, J., Qi, C., Zhao, W., Han, S.-Y., Liu, M., et al. (2018) · Aquaculture Nutrition · doi:10.1111/anu.12688 · Cited by 16
Turn motif phosphorylation negatively regulates activation loop phosphorylation in Akt
Hiraoka, D., Okumura, E., & Kishimoto, T. (2011) · Oncogene · doi:10.1038/onc.2011.155 · Cited by 17
Davis, R. J., Swanger, J., Hughes, B. T., & Clurman, B. E. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00657-16 · Cited by 15
Kello, M., Kuruc, T., Petrová, K., Goga, M., Michalová, Z., Čoma, M., Ručová, D., & Mojžíš, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122173 · Cited by 17
Li, Y., Cao, Y., Wu, X. L., Han, G., Wang, L., Zhang, Y., Chen, X., Hao, B., Yue, Z., & Liu, J. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0164-6 · Cited by 15
Jackson, T. C., & Foster, T. C. (2009) · Bioscience hypotheses · doi:10.1016/j.bihy.2009.02.013 · Cited by 14
Calvayrac, O., Pradines, A., & Favre, G. (2016) · Small GTPases · doi:10.1080/21541248.2016.1234429 · Cited by 15
MacKay, K. B., Tu, Y., Young, S. G., & Clarke, S. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065967 · Cited by 14
Zhao, G., Gao, Y., Zhang, J., Zhang, H., Xie, C., Nan, F., Feng, S., Ha, Z., Li, C., Zhu, X., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.989183 · Cited by 14
Chaudhuri, S., Singh, M. K., Bhattacharya, D., Datta, A., Hazra, I., Mondal, S., Sk, O. F., Ronsard, L., Ghosh, T. K., & Chaudhuri, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26047 · Cited by 14
Hajdú, B., Holczer, M., Horváth, G., Szederkényi, G., & Kapuy, O. (2022) · Biomolecules · doi:10.3390/biom12111587 · Cited by 13
Montenegro, M. F., Martí-Díaz, R., Navarro, A., Tolivia, J., Sánchez‐del‐Campo, L., Cabezas‐Herrera, J., & Rodríguez‐López, J. N. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06288-9 · Cited by 13
Zhang, Y., Pan, R., Li, K., Cheang, L. H., Zhao, J., Zhong, Z., Li, S., Wang, J., Zhang, X., Cheng, Y., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.100015 · Cited by 13
Yang, C.-P., Chiang, C.-W., Chen, C.-H., Lee, Y., Wu, M.-H., Tsou, Y.-H., Yang, Y.-S., Chang, W., & Lin, D.-Y. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0136-0 · Cited by 13
Self-citationIn search for biomarkers and potential drug targets for uterine serous endometrial cancer
Dinoi, G., Mariani, A., Martinelli, E., Ciucci, A., Zannoni, G. F., Weaver, A. L., Keeney, G. L., Vasmatzis, G., Anastasiadis, P. Z., Fanfani, F., et al. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03566-x · Cited by 13
Edelstein, J., & Rockwell, P. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.052 · Cited by 13
Longman, M. R., Ranieri, A., Avkiran, M., & Snabaitis, A. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086234 · Cited by 13
PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation
Shahaf, G., Rotem‐Dai, N., Koifman, G., Raveh-Amit, H., Frost, S. A., & Livneh, E. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.01.018 · Cited by 13
Lai, T.-Y., Yen, C.-J., Tsai, H.-W., Yang, Y.-S., Hong, W.-F., & Chiang, C.-W. (2015) · Oncotarget · doi:10.18632/oncotarget.6609 · Cited by 13
Self-citationAnti-tumor effects of perphenazine on canine lymphoma
Tsuji, S., Yabe, R., Usui, T., Mizuno, T., Ohama, T., & Sato, K. (2016) · Journal of Veterinary Medical Science · doi:10.1292/jvms.15-0707 · Cited by 13
Hanawa, S., Mitsuhashi, A., & Shozu, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192759 · Cited by 12
Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma
Li, J., Zhou, J., Mu, X., Shen, S. Y., Xu, X., Luo, Y., Luo, Y., Ming, Y., Wu, Y., & Peng, Y. (2022) · MedComm · doi:10.1002/mco2.125 · Cited by 12
Postmitotic G1 phase survivin drives mitogen-independent cell division of B lymphocytes
Singh, A., Spitzer, M. H., Joy, J. P., Kaileh, M., Qiu, X., Nolan, G. P., & Sen, R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115567119 · Cited by 12
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases
Hribal, M. L., Mancuso, E., Spiga, R., Mannino, G. C., Fiorentino, T. V., Andreozzi, F., & Sesti, G. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1130822 · Cited by 12
Yu, S., Li, L., Wu, Q., Dou, N., Li, Y., & Gao, Y. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4329 · Cited by 11
Hydrogen peroxide formation by Nox4 limits malignant transformationPreprint
Helfinger, V., von Gall, F. F., Henke, N., Kunze, M. M., Schmid, T., Heidler, J., Wittig, I., Radeke, H. H., Marschall, V., Anderson, K. E., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/177055 · Cited by 12
Wasserman, J. S., Faezov, B., Patel, K. R., Kurimchak, A., Palacio, S. M., Glass, D. J., Fowle, H. A., McEwan, B. C., Xu, Q., Zhao, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50015-7 · Cited by 11
PHLPP2 is a pseudophosphatase that lost activity in the metazoan ancestor
Husremović, T., Meier, V., Piëch, L., Siess, K. M., Antonioli, S., Grishkovskaya, I., Kircheva, N., Angelova, S., Wenzl, K., Brandstätter, A., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417218122 · Cited by 13
Interplay between glycogen synthase kinase‐3β and tau in the cerebellum of Hsp27 transgenic mouse
Wang, S., Toth, M. E., Bereczki, E., Sántha, M., Guan, Z., Winblad, B. G., & Pei, J.-J. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22660 · Cited by 11
Dillinger, B., Ahmadi-Erber, S. M., Soukup, K., Halfmann, A., Schrom, S., Vanhove, B., Steinberger, P., Geyeregger, R., Ladisch, S., & Dohnal, A. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01152 · Cited by 11
Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis
Frederick, M. I., Hovey, O. F. J., Kakadia, J. H., Shepherd, T. G., Li, S. S. ‐., & Heinemann, I. U. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100660 · Cited by 11
Fabbrizi, M. R., Meyer, B., Misri, S., Raj, S., Zobel, C. L., Hallahan, D. E., & Sharma, G. G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0559-0 · Cited by 11
Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors
Melick, C. H., & Jewell, J. L. (2020) · Biochemical Journal · doi:10.1042/bcj20190958 · Cited by 13
Tsuji, S., Kohyanagi, N., Mizuno, T., Ohama, T., & Sato, K. (2020) · Oncology Letters · doi:10.3892/ol.2020.12374 · Cited by 10
Ma, Y., Li, S., Ye, S., Luo, S., Wei, L. J., Su, Y., Zeng, Y., Shi, Y., Bian, H., & Xiao, F. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123535 · Cited by 12
Depletion of CLK2 sensitizes glioma stem-like cells to PI3K/mTOR and FGFR inhibitors.
Park, S. Y., Mittal, S., Dong, J., Jeong, K., Martínez-Ledesma, E., Piao, Y., Khan, S., Henry, V. K., Verhaak, R. G. W., Majd, N., et al. (2020) · PubMed Central · Cited by 10
PME ‐1 is regulated by USP 36 in ERK and Akt signaling pathways
Kim, S., Choi, J., Lee, D., Park, J., Hwang, Y., & Baek, K. (2018) · FEBS Letters · doi:10.1002/1873-3468.13039 · Cited by 10
Hsiao, K.-C., Ruan, S.-Y., Chen, S.-M., Lai, T.-Y., Chan, R., Zhang, Y., Chu, C., Cheng, H., Tsai, H., Tu, Y., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01182-5 · Cited by 9
Self-citationIkumawoyi, V. O., Lynch, K. D., Iverson, D. T., Call, M. R., Yue, G. E., Prasad, B., & Clarke, J. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.108072 · Cited by 11
Downregulation of Caveolin-1 Enhances Fusion of Human BeWo Choriocarcinoma Cells
Collett, G. P., Linton, E. A., Redman, C., & Sargent, I. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010529 · Cited by 9
Chan, T. O., Zhang, J., Tiegs, B. C., Blumhof, B., Yan, L. H., Keny, N., Penny, M. K., Li, X., Pascal, J. M., Armen, R. S., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150325 · Cited by 10
Tadele, D. S., Robertson, J. M., Crispin, R., Herrera, M. C., Chlubnová, M., Piechaczyk, L., Durán, P. A., Singh, S. K., Gedde‐Dahl, T., Fløisand, Y., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015285 · Cited by 9
Kim, H. J., Byun, H. J., Park, M. K., Kim, E. J., Kang, G.-J., & Lee, C. H. (2017) · Oncotarget · doi:10.18632/oncotarget.15364 · Cited by 9
Majed, S. O., & Mustafa, S. A. (2021) · BMC Cancer · doi:10.1186/s12885-021-08218-4 · Cited by 9
PIK3IP1: structure, aberration, function, and regulation in diseases
Jia, Y., He, P., Ma, X., Lv, K., Liu, Y., & Xu, Y. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176753 · Cited by 8
Timmerman, L. M., de Graaf, J. F., Satravelas, N., Keşmir, C., Meyaard, L., & van der Vlist, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244770 · Cited by 8
Ivanov, D. K., Papatheodorou, I., Ziehm, M., & Thornton, J. M. (2013) · Molecular BioSystems · doi:10.1039/c3mb25485b · Cited by 8
Regulation of mTOR and p70 S6 kinase by the muscarinic M4 receptor in PC12 cells
Chan, G. P. W., Wu, E. H. T., & Wong, Y. H. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.11.010 · Cited by 8
Lum, M. A., Jonas, K. A., Parmar, S., Black, A. R., O’Connor, C. M., Dobersch, S., Yamamoto, N., Robertson, T. M., Schutter, A., Giambi, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci176093 · Cited by 7
Kim, H. G., Jeong, S.-G., Kim, J. H., & Cho, J. Y. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.09.012 · Cited by 7
PI3K Signaling at the Crossroads of Lipid Metabolism and Cancer
Yilmaz, S., & Cizmecioglu, O. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_832 · Cited by 7
Insights into PI3K / AKT signaling in B cell development and chronic lymphocytic leukemia
Buchner, M. (2024) · FEBS Letters · doi:10.1002/1873-3468.15079 · Cited by 11
An ultrasensitive fiveplex activity assay for cellular kinases
Smolko, C. M., & Janes, K. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-55998-8 · Cited by 7
Galpha16 interacts with Class IA phosphatidylinositol 3-kinases and inhibits Akt signaling.
Yeung, W. W. S., & Wong, Y. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.008 · Cited by 9
Hayashi, T., Hikichi, M., Yukitake, J., Harada, N., & Utsumi, T. (2017) · Oncology Letters · doi:10.3892/ol.2017.7216 · Cited by 7
AKT: A Central Node in Complex Signaling Cascades
Minegishi, K., Dobashi, Y., Kimura, E., & Goto, A. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl26414 · Cited by 7
Jiu, Y., Hasygar, K., Tang, L., Liu, Y., Holmberg, C. I., Bürglin, T. R., Hietakangas, V., & Jäntti, J. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.006718 · Cited by 6
Lou, P., Lucchinetti, E., Hersberger, M., Clanachan, A. S., & Zaugg, M. (2019) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004295 · Cited by 6
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells
Hao, J., Ci, X., Wang, Y., Choi, S. Y. C., Sullivan, S. E., Xue, H., Wu, R., Dong, X., Haegert, A. M., Collins, C. C., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33335 · Cited by 6
Momeny, M., Arsiola, T., & Westermarck, J. K. (2021) · Biochemical Journal · doi:10.1042/bcj20210254 · Cited by 6
Cellular Protein Phosphatase 2A Regulates Cell Survival Mechanisms in Influenza A Virus Infection
Gerlt, V., Mayr, J., Sarto, J. D., Ludwig, S., & Boergeling, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011164 · Cited by 7
Reece, K. M., Mazalouskas, M. D., & Wadzinski, B. E. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.062 · Cited by 6
FTY720 inhibits germ cell apoptosis in testicular torsion/detorsion
Shih, H., Yen, J., Chiu, A. W., Chow, Y.-C., Pan, W. H. T., & Huang, C. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.12.035 · Cited by 6
Huang, P., Chen, K., Ma, T., Cao, N., Weng, D., Xu, C., & Xu, L. (2020) · Environmental Toxicology · doi:10.1002/tox.22907 · Cited by 6
Gu, S., He, W., Yan, M., He, J., Zhou, Q., Yan, X., Fu, X., Chen, J., Han, X., & Qiu, Y. (2020) · Cell Proliferation · doi:10.1111/cpr.12961 · Cited by 6
AKT and DUBs: a bidirectional relationship
Serratore, V., Lucibello, M., Malanga, D., Viglietto, G., & Marco, C. D. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00753-3 · Cited by 6
Li, H., Di, R., & Kong, D. (2026) · Scientific Reports · doi:10.1038/s41598-025-34150-9 · Cited by 5
Wu, J., Liu, H., Li, X., Huang, H., Zhu, H., Wang, J., Yue, H., Li, R., Shu, K., & You, C. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07743-9 · Cited by 5
Omella, J. D., Cortesi, E. E., Verbinnen, I., Remmerie, M., Wu, H., Cubero, F. J., Roskams, T., & Janssens, V. (2023) · Cancers · doi:10.3390/cancers15164193 · Cited by 6
Nguyen, T. T. T., Lu, W., Zhu, W. S., Ansel, K. M., Liang, H.-E., & Weiss, A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300987120 · Cited by 5
Vujovic, F., Shepherd, C. E., Witting, P. K., Hunter, N., & Farahani, R. H. (2023) · Antioxidants · doi:10.3390/antiox12101873 · Cited by 5
Tsuchiya, A., Kanno, T., & Nishizaki, T. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363027 · Cited by 5
Metadata
- Authors
- Kuo, Y.-C., Huang, K.-Y., Yang, C.-H., Yang, Y.-S., Lee, W.-Y., & Chiang, C.-W.
- Affiliations
- National Cheng Kung University (TW)
- Corresponding author
- Chiang, Chi-Wu
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 283
- Issue
- 4
- Pages
- 1882-1892
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2045852899
- Cited by
- 367
- References
- 72
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 14 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 20 · 2018: 25 · 2017: 30 · 2016: 20 · 2015: 32 · 2014: 26 · 2013: 18 · 2012: 17
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Akt, protein phosphatase 2A, PP2A holoenzyme, Akt dephosphorylation, FOXO3, cell proliferation, cell survival, NIH3T3 cells
- MeSH terms
- Animals, Cell Survival, Humans, Interleukin-3, Phosphorylation, Holoenzymes, Gene Silencing, NIH 3T3 Cells, Cell Proliferation, Proto-Oncogene Proteins c-akt, Mice, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review